Adequan Equine I.M., 100mg/ml 50ml Vial

Description: Adequan® I.M. Equine is the only FDA approved equine polysulfated glycosaminoglycan (PSGAG) for the intramuscular treatment of non–infectious degenerative and⁄or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

Product: Adequan® I.M. EQUINE Injectable for Horses

For: Horses

Generic Name: Polysulfated glycosaminoglycan

Brand Names: Adequan® I.M. Equine

Drug Class: Proteolytic enzyme inhibitor, Chondroprotectant

Manufacturer: American Regent Animal Health

Product Description & Form: Adequan® I.M. 100 mg⁄ml Equine 5 ml (1 ct & 7 ct) & 50 ml: Colorless solution (NDC 10797–0995–01, 10797–0995–70, 10797–0959–01) Adequan® I.M. 100 mg⁄ml Equine 5 ml (1 ct & 7 ct) & 50 ml

Benefits:

Diminish the destructive processes of degenerative joint disease

Reverse the processes which result in the loss of cartilage components

Improve overall joint function and associated lameness

Stimulates cartilage repair

Restore synovial lubrication